ID: h-var-92a02b86a1
Hypothesis

CREB-Dependent Differential Complement Regulator Positioning for Activity-Based Synaptic Vulnerability Control

This hypothesis proposes that the CREB-BDNF-TrkB activity-dependent signaling cascade directly controls the spatial positioning and expression levels of complement regulators CD55 and CD46 on synaptic membranes, creating an activity-base.
🧬 CREB1, CD55, CD46🩺 synaptic-biology🎯 Composite 83%validated
synaptic biology
EvidencePending (0%)📖 16 cit🗣 1 debates 9 support 2 oppose
⚠ Low Validation Senate Quality Gates →
Mechanistic 0.75 (15%) Evidence 0.72 (15%) Novelty 0.75 (12%) Feasibility 0.70 (12%) Impact 0.80 (12%) Druggability 0.70 (10%) Safety 0.50 (8%) Competition 0.80 (6%) Data Avail. 0.55 (5%) Reproducible 0.72 (5%) KG Connect 0.50 (8%) 0.833 composite

🧪 Overview

This hypothesis proposes that the CREB-BDNF-TrkB activity-dependent signaling cascade directly controls the spatial positioning and expression levels of complement regulators CD55 and CD46 on synaptic membranes, creating an activity-based tagging system for synaptic elimination. High-frequency neural activity triggers calcium influx and CaMKIV/PKA-mediated CREB1 phosphorylation at serine 133, which transcriptionally upregulates CD55 and CD46 expression while simultaneously promoting their trafficking to active synapses through BDNF-TrkB signaling. The TrkB-activated PI3K/Akt pathway enhances surface insertion of CD55/CD46 at frequently stimulated synapses by phosphorylating trafficking proteins and stabilizing regulator clustering, while the Ras/MAPK cascade reinforces this protective phenotype through sustained CREB activation. Conversely, synapses with low activity levels exhibit reduced CREB-mediated transcription, leading to diminished CD55 and CD46 surface expression and creating microdomains of complement vulnerability.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["CD55 DAF, CD46 MCP<br/>Hypothesis Target"]
    B["Complement<br/>Cited Mechanism"]
    C["Cellular Response<br/>Stress or Clearance Change"]
    D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
    E["Neurodegeneration<br/>Disease-Relevant Outcome"]
    A --> B
    B --> C
    C --> D
    D --> E
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix9 supports2 contradicts
Supports
CD55 protects synapses from complement-mediated damage
Supports
C3aR1 mediates microglial recruitment to injured neurons
Supports
Dendritic spine CD46 expression is activity-dependent
Supports
Beyond the Role of CD55 as a Complement Component.
Immune Netw2018PMID:29503741medium
Supports
Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade.
Nat Cancer2022PMID:36271172medium
Supports
Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells.
Cell Biol Int2012PMID:22574734medium
Supports
Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide.
FEBS J2013PMID:23176121medium
Supports
Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer.
Mol Cancer2024PMID:38853277medium
Supports
CD46 cofactor activity at active synapses enhances factor I-mediated cleavage of C3b and C4b, blocking complement amplification on synaptic membranes
Contradicts
C1q binding can occur independent of complement cascade initiation through pattern recognition
Contradicts
Global complement enhancement could impair necessary synaptic remodeling
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — CREB1

No curated PDB or AlphaFold mapping for CREB1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for CREB1, CD55, CD46 →

No DepMap CRISPR Chronos data found for CREB1, CD55, CD46.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

💾 Resource Usage

LLM Tokens
27,622
$0.0829
Total Cost
$0.0829
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.